Entrada Therapeutics Inc had a revenue of 20.56M in the quarter ending Mar 31, 2025, with -45.03%. This bring the company's revenue in the last twelve months to 172.22M, Increased -18.29%. In the fiscal year ending Dec 31, 2024, Entrada Therapeutics Inc had annual revenue of 210.78M with 63.38% growth.